Mildly elevated serum bilirubin and its correlations with lipid levels among male patients undergoing health checkups
Background Bilirubin's ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The present study aimed to elucidate the correlations of the two subtypes of bilirubin with lipid levels. Methods A total of 1732 male patients unde...
Saved in:
Published in | Lipids in health and disease Vol. 22; no. 1; pp. 1 - 8 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central Ltd
04.12.2023
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background Bilirubin's ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The present study aimed to elucidate the correlations of the two subtypes of bilirubin with lipid levels. Methods A total of 1732 male patients undergoing health checkups were categorized into three groups according to the levels of direct bilirubin (DBil) and indirect bilirubin (IBil). The differences in medical characteristics among the three groups were analysed. Results Subjects in the elevated DBil group had the lowest serum alanine aminotransferase (ALT), total cholesterol (TC), blood urea nitrogen (BUN), [gamma]-glutamyl transpeptidase ([gamma]-GT), fasting blood glucose (FBG), haemoglobin (HGB), and triglyceride (TG) levels in contrast to the other groups (P < 0.01), while subjects in the elevated IBil group had the highest ALT, [gamma]-GT, BUN, serum creatinine (SCR), HGB, TC, and TG levels among the three groups (P < 0.01). DBil levels exhibited a significant negative correlation with TC (r = -0.777, P < 0.01) and TG (r = -0.397, P < 0.01) levels, while IBil levels exhibited a significant positive correlation with TC (r = 0.790, P < 0.01) and TG (r = 0.302, P < 0.01) levels. The frequencies of abnormal TC, TG, HGB and BUN levels were the lowest in the elevated DBil group, while the levels of these four variables were the highest in the elevated IBil group. Mildly elevated DBil levels were related to lower TG (OR = 0.112, 95% CI = 0.027-0.458) and TC (OR = 0.097, 95% CI = 0.013-0.700), and mildly elevated IBil levels were connected with increased TC (OR = 3.436, 95% CI = 2.398-4.924) and TG (OR = 1.636, 95% CI = 1.163-2.303). DBil was an independent protective factor against increased TC (OR = 0.702, 95% CI = 0.602-0.817, P < 0.01) and TG (OR = 0.632, 95% CI = 0.541-0.739, P < 0.01) levels, and IBil was an independent risk factors for increased TC (OR = 1.251, 95% CI = 1.176-1.331, P < 0.01). Conclusions DBil was an independent protective factor against high TC and TG levels. IBil was an independent risk factors for elevated TC levels. The prognostic value of IBil levels warrants further attention. Keywords: Direct bilirubin (DBil), Triglyceride (TG), Indirect bilirubin (IBil), Total cholesterol (TC), Total bilirubin (TBil) |
---|---|
AbstractList | Background Bilirubin's ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The present study aimed to elucidate the correlations of the two subtypes of bilirubin with lipid levels. Methods A total of 1732 male patients undergoing health checkups were categorized into three groups according to the levels of direct bilirubin (DBil) and indirect bilirubin (IBil). The differences in medical characteristics among the three groups were analysed. Results Subjects in the elevated DBil group had the lowest serum alanine aminotransferase (ALT), total cholesterol (TC), blood urea nitrogen (BUN), [gamma]-glutamyl transpeptidase ([gamma]-GT), fasting blood glucose (FBG), haemoglobin (HGB), and triglyceride (TG) levels in contrast to the other groups (P < 0.01), while subjects in the elevated IBil group had the highest ALT, [gamma]-GT, BUN, serum creatinine (SCR), HGB, TC, and TG levels among the three groups (P < 0.01). DBil levels exhibited a significant negative correlation with TC (r = -0.777, P < 0.01) and TG (r = -0.397, P < 0.01) levels, while IBil levels exhibited a significant positive correlation with TC (r = 0.790, P < 0.01) and TG (r = 0.302, P < 0.01) levels. The frequencies of abnormal TC, TG, HGB and BUN levels were the lowest in the elevated DBil group, while the levels of these four variables were the highest in the elevated IBil group. Mildly elevated DBil levels were related to lower TG (OR = 0.112, 95% CI = 0.027-0.458) and TC (OR = 0.097, 95% CI = 0.013-0.700), and mildly elevated IBil levels were connected with increased TC (OR = 3.436, 95% CI = 2.398-4.924) and TG (OR = 1.636, 95% CI = 1.163-2.303). DBil was an independent protective factor against increased TC (OR = 0.702, 95% CI = 0.602-0.817, P < 0.01) and TG (OR = 0.632, 95% CI = 0.541-0.739, P < 0.01) levels, and IBil was an independent risk factors for increased TC (OR = 1.251, 95% CI = 1.176-1.331, P < 0.01). Conclusions DBil was an independent protective factor against high TC and TG levels. IBil was an independent risk factors for elevated TC levels. The prognostic value of IBil levels warrants further attention. Keywords: Direct bilirubin (DBil), Triglyceride (TG), Indirect bilirubin (IBil), Total cholesterol (TC), Total bilirubin (TBil) Abstract Background Bilirubin’s ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The present study aimed to elucidate the correlations of the two subtypes of bilirubin with lipid levels. Methods A total of 1732 male patients undergoing health checkups were categorized into three groups according to the levels of direct bilirubin (DBil) and indirect bilirubin (IBil). The differences in medical characteristics among the three groups were analysed. Results Subjects in the elevated DBil group had the lowest serum alanine aminotransferase (ALT), total cholesterol (TC), blood urea nitrogen (BUN), γ-glutamyl transpeptidase (γ-GT), fasting blood glucose (FBG), haemoglobin (HGB), and triglyceride (TG) levels in contrast to the other groups (P < 0.01), while subjects in the elevated IBil group had the highest ALT, γ-GT, BUN, serum creatinine (SCR), HGB, TC, and TG levels among the three groups (P < 0.01). DBil levels exhibited a significant negative correlation with TC (r = -0.777, P < 0.01) and TG (r = -0.397, P < 0.01) levels, while IBil levels exhibited a significant positive correlation with TC (r = 0.790, P < 0.01) and TG (r = 0.302, P < 0.01) levels. The frequencies of abnormal TC, TG, HGB and BUN levels were the lowest in the elevated DBil group, while the levels of these four variables were the highest in the elevated IBil group. Mildly elevated DBil levels were related to lower TG (OR = 0.112, 95% CI = 0.027–0.458) and TC (OR = 0.097, 95% CI = 0.013–0.700), and mildly elevated IBil levels were connected with increased TC (OR = 3.436, 95% CI = 2.398–4.924) and TG (OR = 1.636, 95% CI = 1.163–2.303). DBil was an independent protective factor against increased TC (OR = 0.702, 95% CI = 0.602–0.817, P < 0.01) and TG (OR = 0.632, 95% CI = 0.541–0.739, P < 0.01) levels, and IBil was an independent risk factors for increased TC (OR = 1.251, 95% CI = 1.176–1.331, P < 0.01). Conclusions DBil was an independent protective factor against high TC and TG levels. IBil was an independent risk factors for elevated TC levels. The prognostic value of IBil levels warrants further attention. BackgroundBilirubin’s ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The present study aimed to elucidate the correlations of the two subtypes of bilirubin with lipid levels.MethodsA total of 1732 male patients undergoing health checkups were categorized into three groups according to the levels of direct bilirubin (DBil) and indirect bilirubin (IBil). The differences in medical characteristics among the three groups were analysed.ResultsSubjects in the elevated DBil group had the lowest serum alanine aminotransferase (ALT), total cholesterol (TC), blood urea nitrogen (BUN), γ-glutamyl transpeptidase (γ-GT), fasting blood glucose (FBG), haemoglobin (HGB), and triglyceride (TG) levels in contrast to the other groups (P < 0.01), while subjects in the elevated IBil group had the highest ALT, γ-GT, BUN, serum creatinine (SCR), HGB, TC, and TG levels among the three groups (P < 0.01). DBil levels exhibited a significant negative correlation with TC (r = -0.777,P < 0.01) and TG (r = -0.397,P < 0.01) levels, while IBil levels exhibited a significant positive correlation with TC (r = 0.790,P < 0.01) and TG (r = 0.302,P < 0.01) levels. The frequencies of abnormal TC, TG, HGB and BUN levels were the lowest in the elevated DBil group, while the levels of these four variables were the highest in the elevated IBil group. Mildly elevated DBil levels were related to lower TG (OR = 0.112, 95% CI = 0.027–0.458) and TC (OR = 0.097, 95% CI = 0.013–0.700), and mildly elevated IBil levels were connected with increased TC (OR = 3.436, 95% CI = 2.398–4.924) and TG (OR = 1.636, 95% CI = 1.163–2.303). DBil was an independent protective factor against increased TC (OR = 0.702, 95% CI = 0.602–0.817, P < 0.01) and TG (OR = 0.632, 95% CI = 0.541–0.739, P < 0.01) levels, and IBil was an independent risk factors for increased TC (OR = 1.251, 95% CI = 1.176–1.331, P < 0.01).ConclusionsDBil was an independent protective factor against high TC and TG levels. IBil was an independent risk factors for elevated TC levels. The prognostic value of IBil levels warrants further attention. Bilirubin's ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The present study aimed to elucidate the correlations of the two subtypes of bilirubin with lipid levels.BACKGROUNDBilirubin's ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The present study aimed to elucidate the correlations of the two subtypes of bilirubin with lipid levels.A total of 1732 male patients undergoing health checkups were categorized into three groups according to the levels of direct bilirubin (DBil) and indirect bilirubin (IBil). The differences in medical characteristics among the three groups were analysed.METHODSA total of 1732 male patients undergoing health checkups were categorized into three groups according to the levels of direct bilirubin (DBil) and indirect bilirubin (IBil). The differences in medical characteristics among the three groups were analysed.Subjects in the elevated DBil group had the lowest serum alanine aminotransferase (ALT), total cholesterol (TC), blood urea nitrogen (BUN), γ-glutamyl transpeptidase (γ-GT), fasting blood glucose (FBG), haemoglobin (HGB), and triglyceride (TG) levels in contrast to the other groups (P < 0.01), while subjects in the elevated IBil group had the highest ALT, γ-GT, BUN, serum creatinine (SCR), HGB, TC, and TG levels among the three groups (P < 0.01). DBil levels exhibited a significant negative correlation with TC (r = -0.777, P < 0.01) and TG (r = -0.397, P < 0.01) levels, while IBil levels exhibited a significant positive correlation with TC (r = 0.790, P < 0.01) and TG (r = 0.302, P < 0.01) levels. The frequencies of abnormal TC, TG, HGB and BUN levels were the lowest in the elevated DBil group, while the levels of these four variables were the highest in the elevated IBil group. Mildly elevated DBil levels were related to lower TG (OR = 0.112, 95% CI = 0.027-0.458) and TC (OR = 0.097, 95% CI = 0.013-0.700), and mildly elevated IBil levels were connected with increased TC (OR = 3.436, 95% CI = 2.398-4.924) and TG (OR = 1.636, 95% CI = 1.163-2.303). DBil was an independent protective factor against increased TC (OR = 0.702, 95% CI = 0.602-0.817, P < 0.01) and TG (OR = 0.632, 95% CI = 0.541-0.739, P < 0.01) levels, and IBil was an independent risk factors for increased TC (OR = 1.251, 95% CI = 1.176-1.331, P < 0.01).RESULTSSubjects in the elevated DBil group had the lowest serum alanine aminotransferase (ALT), total cholesterol (TC), blood urea nitrogen (BUN), γ-glutamyl transpeptidase (γ-GT), fasting blood glucose (FBG), haemoglobin (HGB), and triglyceride (TG) levels in contrast to the other groups (P < 0.01), while subjects in the elevated IBil group had the highest ALT, γ-GT, BUN, serum creatinine (SCR), HGB, TC, and TG levels among the three groups (P < 0.01). DBil levels exhibited a significant negative correlation with TC (r = -0.777, P < 0.01) and TG (r = -0.397, P < 0.01) levels, while IBil levels exhibited a significant positive correlation with TC (r = 0.790, P < 0.01) and TG (r = 0.302, P < 0.01) levels. The frequencies of abnormal TC, TG, HGB and BUN levels were the lowest in the elevated DBil group, while the levels of these four variables were the highest in the elevated IBil group. Mildly elevated DBil levels were related to lower TG (OR = 0.112, 95% CI = 0.027-0.458) and TC (OR = 0.097, 95% CI = 0.013-0.700), and mildly elevated IBil levels were connected with increased TC (OR = 3.436, 95% CI = 2.398-4.924) and TG (OR = 1.636, 95% CI = 1.163-2.303). DBil was an independent protective factor against increased TC (OR = 0.702, 95% CI = 0.602-0.817, P < 0.01) and TG (OR = 0.632, 95% CI = 0.541-0.739, P < 0.01) levels, and IBil was an independent risk factors for increased TC (OR = 1.251, 95% CI = 1.176-1.331, P < 0.01).DBil was an independent protective factor against high TC and TG levels. IBil was an independent risk factors for elevated TC levels. The prognostic value of IBil levels warrants further attention.CONCLUSIONSDBil was an independent protective factor against high TC and TG levels. IBil was an independent risk factors for elevated TC levels. The prognostic value of IBil levels warrants further attention. Bilirubin's ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The present study aimed to elucidate the correlations of the two subtypes of bilirubin with lipid levels. A total of 1732 male patients undergoing health checkups were categorized into three groups according to the levels of direct bilirubin (DBil) and indirect bilirubin (IBil). The differences in medical characteristics among the three groups were analysed. Subjects in the elevated DBil group had the lowest serum alanine aminotransferase (ALT), total cholesterol (TC), blood urea nitrogen (BUN), [gamma]-glutamyl transpeptidase ([gamma]-GT), fasting blood glucose (FBG), haemoglobin (HGB), and triglyceride (TG) levels in contrast to the other groups (P < 0.01), while subjects in the elevated IBil group had the highest ALT, [gamma]-GT, BUN, serum creatinine (SCR), HGB, TC, and TG levels among the three groups (P < 0.01). DBil levels exhibited a significant negative correlation with TC (r = -0.777, P < 0.01) and TG (r = -0.397, P < 0.01) levels, while IBil levels exhibited a significant positive correlation with TC (r = 0.790, P < 0.01) and TG (r = 0.302, P < 0.01) levels. The frequencies of abnormal TC, TG, HGB and BUN levels were the lowest in the elevated DBil group, while the levels of these four variables were the highest in the elevated IBil group. Mildly elevated DBil levels were related to lower TG (OR = 0.112, 95% CI = 0.027-0.458) and TC (OR = 0.097, 95% CI = 0.013-0.700), and mildly elevated IBil levels were connected with increased TC (OR = 3.436, 95% CI = 2.398-4.924) and TG (OR = 1.636, 95% CI = 1.163-2.303). DBil was an independent protective factor against increased TC (OR = 0.702, 95% CI = 0.602-0.817, P < 0.01) and TG (OR = 0.632, 95% CI = 0.541-0.739, P < 0.01) levels, and IBil was an independent risk factors for increased TC (OR = 1.251, 95% CI = 1.176-1.331, P < 0.01). DBil was an independent protective factor against high TC and TG levels. IBil was an independent risk factors for elevated TC levels. The prognostic value of IBil levels warrants further attention. |
ArticleNumber | 213 |
Audience | Academic |
Author | Zhang, Hong Bai, Xin Qiao, Jing |
Author_xml | – sequence: 1 givenname: Xin surname: Bai fullname: Bai, Xin – sequence: 2 givenname: Jing surname: Qiao fullname: Qiao, Jing – sequence: 3 givenname: Hong surname: Zhang fullname: Zhang, Hong |
BookMark | eNptUk1r3DAQNSWFJmn_QE-CXnpxog9btk4lhKYJpPTSQm9CH2OvtrLkSnaW_Ptqs6HtliIYDTPvvWGGd1adhBigqt4SfEFIzy8zoaJpakxZjYnoRL17UZ2SpuN1S8j3k7_yV9VZzluMKe44P63Wz85b_4jAw4NawKIMaZ2Qdt6lVbuAVLDILRmZmBJ4tbgYMtq5ZYO8m51FhQc-IzXFMKJJeUBzAUEolDVYSGN0pbEB5QvFbMD8WOf8uno5KJ_hzfN_Xn27-fj1-ra-__Lp7vrqvjaNoEs9GMwFbQdBG6xoa0AP2gxKcNYIYqlhVBPda2pKELgjqmWgDWGKWeBcWXZe3R10bVRbOSc3qfQoo3LyqRDTKFVanPEgle01EKo5L4ccVKPbDlpgvbFG88ayovXhoDWvegJryopJ-SPR405wGznGB0nKEo1o9wrvnxVS_LlCXuTksgHvVYC4Zkl70TPCMG0L9N0_0G1cUyi3klRgSliJ_A9qLHeXLgyxDDZ7UXnVdW3TEcH2Yy_-gyrPwuRM8dHgSv2IQA8Ek2LOCYbfSxIs93aTB7vJYjf5ZDe5Y78AFvLNFg |
Cites_doi | 10.1042/CS20120661 10.1016/S0021-9150(01)00601-3 10.1016/0304-4165(93)90013-X 10.1152/ajpgi.2000.279.2.G356 10.1152/physiolgenomics.00028.2019 10.1186/s13098-021-00762-0 10.3109/10641963.2015.1060990 10.3389/fendo.2021.792795 10.1371/journal.pone.0193041 10.1186/s12933-022-01484-x 10.1186/s12883-021-02398-z 10.1016/j.atherosclerosis.2017.12.021 10.1016/j.atherosclerosis.2014.05.927 10.1016/j.plipres.2023.101235 10.1111/j.1753-0407.2011.00138.x 10.1152/ajpendo.00405.2020 10.1016/j.bbadis.2021.166079 10.1016/j.atherosclerosis.2014.12.053 10.1373/clinchem.2010.151043 10.1038/pr.2015.247 10.1161/01.ATV.8.4.368 10.1016/j.atherosclerosis.2020.12.005 10.1016/j.ajpc.2021.100149 10.1016/j.clinbiochem.2014.08.014 10.1186/s12944-018-0857-7 10.18632/aging.100004 10.1126/science.1204265 10.3390/ijms17122093 10.1007/s11745-010-3408-1 10.1016/j.jhep.2021.06.010 10.1016/j.molmed.2023.01.007 10.1016/j.numecd.2011.03.001 10.1016/0005-2760(88)90235-4 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2023 BioMed Central Ltd. 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2023. The Author(s). The Author(s) 2023 |
Copyright_xml | – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2023. The Author(s). – notice: The Author(s) 2023 |
DBID | AAYXX CITATION 3V. 7X7 7XB 88E 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 7X8 5PM DOA |
DOI | 10.1186/s12944-023-01979-w |
DatabaseName | CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1476-511X |
EndPage | 8 |
ExternalDocumentID | oai_doaj_org_article_ad8be12b66944fa4b57e5e38cdcb64d3 PMC10694953 A775471933 10_1186_s12944_023_01979_w |
GeographicLocations | China United States--US Chicago Illinois |
GeographicLocations_xml | – name: China – name: United States--US – name: Chicago Illinois |
GroupedDBID | --- 0R~ 29L 2WC 53G 5GY 5VS 7X7 88E 8FE 8FH 8FI 8FJ A8Z AAFWJ AAHBH AAJSJ AASML AAYXX ABDBF ABUWG ACGFO ACGFS ACPRK ACUHS ADBBV ADRAZ ADUKV AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IGS IHR INH INR ITC KQ8 LK8 M1P M48 M7P M~E O5R O5S OK1 OVT P2P P6G PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB PMFND 3V. 7XB 8FD 8FK AZQEC DWQXO FR3 GNUQQ K9. P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c492t-fc06925f9240a25cebfbcfa963491d2c32b1b8b2cb8b9071a53ebc13a3de66ad3 |
IEDL.DBID | M48 |
ISSN | 1476-511X |
IngestDate | Wed Aug 27 01:31:58 EDT 2025 Thu Aug 21 18:36:01 EDT 2025 Thu Jul 10 22:45:55 EDT 2025 Fri Jul 25 10:56:10 EDT 2025 Tue Jun 17 22:22:58 EDT 2025 Tue Jun 10 21:15:56 EDT 2025 Tue Jul 01 00:23:20 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c492t-fc06925f9240a25cebfbcfa963491d2c32b1b8b2cb8b9071a53ebc13a3de66ad3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12944-023-01979-w |
PQID | 2902132906 |
PQPubID | 42587 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_ad8be12b66944fa4b57e5e38cdcb64d3 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10694953 proquest_miscellaneous_2898313025 proquest_journals_2902132906 gale_infotracmisc_A775471933 gale_infotracacademiconefile_A775471933 crossref_primary_10_1186_s12944_023_01979_w |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-12-04 |
PublicationDateYYYYMMDD | 2023-12-04 |
PublicationDate_xml | – month: 12 year: 2023 text: 2023-12-04 day: 04 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationTitle | Lipids in health and disease |
PublicationYear | 2023 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | N SeyedKhoei (1979_CR23) 2022; 21 Q Ouyang (1979_CR20) 2021; 21 Y Wei (1979_CR21) 2021; 13 L Vitek (1979_CR8) 2002; 160 L Vitek (1979_CR18) 2023; 29 L Calabresi (1979_CR32) 2010; 20 V Petrenko (1979_CR2) 2023; 91 HE Bays (1979_CR4) 2021; 5 R Kawamoto (1979_CR12) 2016; 38 J Fu (1979_CR22) 2022; 12 X Zhang (1979_CR25) 2018; 17 SH Choi (1979_CR16) 2013; 23 G Perdomo (1979_CR33) 2009; 1 M Grabacka (1979_CR27) 2016; 17 W Goessling (1979_CR34) 2000; 279 G Camejo (1979_CR28) 1988; 8 T Nakagami (1979_CR29) 1993; 1158 JC Cohen (1979_CR5) 2011; 332 L Vitek (1979_CR6) 2021; 75 N SeyedKhoei (1979_CR10) 2018; 269 S Suh (1979_CR14) 2018; 13 B Stieger (1979_CR1) 2021; 1867 K Musunuru (1979_CR3) 2010; 45 E Oda (1979_CR15) 2014; 235 DM Gordon (1979_CR26) 2019; 51 E Oda (1979_CR24) 2015; 239 JF Creeden (1979_CR17) 2021; 320 L Hou (1979_CR19) 2021; 320 N Memon (1979_CR7) 2016; 79 JP Lin (1979_CR13) 2010; 56 M Wallner (1979_CR9) 2013; 125 R Saeedi (1979_CR31) 2015; 48 E Steyrer (1979_CR30) 1988; 985 Y Wu (1979_CR11) 2011; 3 |
References_xml | – volume: 125 start-page: 257 year: 2013 ident: 1979_CR9 publication-title: Clin Sci (Lond) doi: 10.1042/CS20120661 – volume: 160 start-page: 449 year: 2002 ident: 1979_CR8 publication-title: Atherosclerosis doi: 10.1016/S0021-9150(01)00601-3 – volume: 1158 start-page: 189 year: 1993 ident: 1979_CR29 publication-title: Biochim Biophys Acta doi: 10.1016/0304-4165(93)90013-X – volume: 20 start-page: 50 year: 2010 ident: 1979_CR32 publication-title: Cardiovasc Med – volume: 279 start-page: G356 year: 2000 ident: 1979_CR34 publication-title: Am J Physiol Gastrointest Liver Physiol doi: 10.1152/ajpgi.2000.279.2.G356 – volume: 51 start-page: 234 year: 2019 ident: 1979_CR26 publication-title: Physiol Genomics doi: 10.1152/physiolgenomics.00028.2019 – volume: 13 start-page: 143 year: 2021 ident: 1979_CR21 publication-title: Diabetol Metab Syndr doi: 10.1186/s13098-021-00762-0 – volume: 38 start-page: 107 year: 2016 ident: 1979_CR12 publication-title: Clin Exp Hypertens doi: 10.3109/10641963.2015.1060990 – volume: 12 start-page: 792795 year: 2022 ident: 1979_CR22 publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2021.792795 – volume: 13 start-page: e0193041 year: 2018 ident: 1979_CR14 publication-title: PLoS ONE doi: 10.1371/journal.pone.0193041 – volume: 21 start-page: 54 year: 2022 ident: 1979_CR23 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-022-01484-x – volume: 21 start-page: 373 year: 2021 ident: 1979_CR20 publication-title: BMC Neurol doi: 10.1186/s12883-021-02398-z – volume: 269 start-page: 306 year: 2018 ident: 1979_CR10 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2017.12.021 – volume: 235 start-page: 334 year: 2014 ident: 1979_CR15 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2014.05.927 – volume: 91 start-page: 101235 year: 2023 ident: 1979_CR2 publication-title: Prog Lipid Res doi: 10.1016/j.plipres.2023.101235 – volume: 3 start-page: 217 year: 2011 ident: 1979_CR11 publication-title: J Diabetes doi: 10.1111/j.1753-0407.2011.00138.x – volume: 320 start-page: E191 year: 2021 ident: 1979_CR17 publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00405.2020 – volume: 1867 start-page: 166079 year: 2021 ident: 1979_CR1 publication-title: Biochim Biophys Acta Mol Basis Dis doi: 10.1016/j.bbadis.2021.166079 – volume: 239 start-page: 31 year: 2015 ident: 1979_CR24 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2014.12.053 – volume: 56 start-page: 1535 year: 2010 ident: 1979_CR13 publication-title: Clin Chem doi: 10.1373/clinchem.2010.151043 – volume: 79 start-page: 378 year: 2016 ident: 1979_CR7 publication-title: Pediatr Res doi: 10.1038/pr.2015.247 – volume: 8 start-page: 368 year: 1988 ident: 1979_CR28 publication-title: Arteriosclerosis doi: 10.1161/01.ATV.8.4.368 – volume: 320 start-page: 112 year: 2021 ident: 1979_CR19 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2020.12.005 – volume: 5 start-page: 100149 year: 2021 ident: 1979_CR4 publication-title: Am J Prev Cardiol doi: 10.1016/j.ajpc.2021.100149 – volume: 48 start-page: 472 year: 2015 ident: 1979_CR31 publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2014.08.014 – volume: 17 start-page: 217 year: 2018 ident: 1979_CR25 publication-title: Lipids Health Dis doi: 10.1186/s12944-018-0857-7 – volume: 1 start-page: 17 year: 2009 ident: 1979_CR33 publication-title: Aging (Albany NY) doi: 10.18632/aging.100004 – volume: 332 start-page: 1519 year: 2011 ident: 1979_CR5 publication-title: Science doi: 10.1126/science.1204265 – volume: 17 start-page: 2093 year: 2016 ident: 1979_CR27 publication-title: Int J Mol Sci doi: 10.3390/ijms17122093 – volume: 45 start-page: 907 year: 2010 ident: 1979_CR3 publication-title: Lipids doi: 10.1007/s11745-010-3408-1 – volume: 75 start-page: 1485 year: 2021 ident: 1979_CR6 publication-title: J Hepatol doi: 10.1016/j.jhep.2021.06.010 – volume: 29 start-page: 315 year: 2023 ident: 1979_CR18 publication-title: Trends Mol Med doi: 10.1016/j.molmed.2023.01.007 – volume: 23 start-page: 31 year: 2013 ident: 1979_CR16 publication-title: Nutr Metab Cardiovasc Dis doi: 10.1016/j.numecd.2011.03.001 – volume: 985 start-page: 484 year: 1988 ident: 1979_CR30 publication-title: Biochim Biophys Acta doi: 10.1016/0005-2760(88)90235-4 |
SSID | ssj0020766 |
Score | 2.3704636 |
Snippet | Background Bilirubin's ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The present... Bilirubin's ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The present study aimed... BackgroundBilirubin’s ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The present... Abstract Background Bilirubin’s ability to lower lipid levels was confirmed by several studies, but those studies mainly focused on total bilirubin (TBil). The... |
SourceID | doaj pubmedcentral proquest gale crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 1 |
SubjectTerms | Alanine transaminase Bilirubin Blood lipids Blood pressure Body mass index Cholesterol Correlation analysis Creatinine Direct bilirubin (DBil) Disease Health aspects Hemoglobin Hyperlipidemia Indirect bilirubin (IBil) Laboratories Lipids Measurement Metabolism Normal distribution Physiological aspects Physiology Prognosis Risk factors Statistical analysis Total bilirubin (TBil) Total cholesterol (TC) Triglyceride (TG) Variables γ-Glutamyltransferase |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLghbEQqmMhOCAoq6fsY9bRFUhLScq9Wb5FYjYza42G1X998wk2aqBAxcuOcSOZHtmMvPZM58JeQ9ejemoQpG9xJIcpovgUy40QGfGQmWUweLk5Td9dS2_3qibB1d9YU7YQA88LNy5TyZkxoPWVsrKy6DKrLIwMcWgZep5PsHnHcDUCLUAnetDiYzR5y14NSkL8E8AnW1pi9uJG-rZ-v_-J_-ZJ_nA8Vw-I0_HiJEuhpE-J49yc0xOFg2g5fUd_UD7HM5-c_yYPF6OR-UnpFvWq7S6o1g_DvFkoqBr3ZpiLuyuAzhMfZNovW9pxPs5xow4ituydFVv60RXmE7U0v42IrqGMdORg7WlWHi2-7EBr0eHOkoKoo-_um37glxffvn--aoY71goorR8X1Rxri1XFcCwuecq5lCFWHkwS2lZ4lHwwIIJPMIDcDTzSuQQmfAiZa19Ei_JUbNp8itCs50nwU0yUWgZPMDuWGbDK89SJUqlZuTTYcnddqDScD0EMdoNAnIgINcLyN3OyAVK5b4n0mD3L0A53Kgc7l_KMSMfUaYOjRUkGP1YcwADRtort0D-vxJiWOh5OukJRhanzQetcKORt45bCJAE8uXPyLv7ZvwSE9eavOmgj7FG4OEwTN9MtGkys2lLU__sib4ZViVbJV7_j7V4Q55wNABMxZGn5Gi_6_JbCKj24ay3nd93ayKS priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwELZgSIgXNDYQhYGMhOABRavt2HGepoKYJqTyxKS-Wf6VEdEmXdNo2n_PXepuBCRe8hA7Spy78_mz774j5D14Naa8dFm0OabkMJU5G2KmADoz5iotNSYnz7-ri8v820Iu0oZbl8Iq93PiMFGH1uMe-SkvwRsJJCc_W19nWDUKT1dTCY2H5BFSl6FWF4t7wAUYXe0TZbQ67cC35XkGXgoAdFmU2c3IGQ2c_f_OzH9HS_7hfs4PydO0bqSznaCfkQexOSLHswYw8-qWfqBDJOewRX5EHs_Tgfkx6ef1MixvKWaRw6oyUNC4fkUxInbTAyimtgm03nbUY5WOFBdHcXOWLut1HegSg4o6OtQkoiv4ZpqYWDuK6WebqxZ8H91lU1JQAP-rX3fPyeX51x9fLrJUaSHzecm3WeWnquSyAjA2tVz66CrnKwvGmZcscC-4Y0477uECaJpZKaLzTFgRolI2iBfkoGmb-JLQWE6D4DpoL1TuLIBvX0TNK8tCJQopJ-TT_peb9Y5QwwxARCuzE5ABAZlBQOZmQj6jVO56Ihn2cKPdXJlkW8YG7SLjTil4urK5k0WUUWgfvFN5EBPyEWVq0GRBgt6mzAP4YCS_MjNkASxgJQs9T0Y9wdT8uHmvFSaZemfuFXNC3t0145MYvtbEtoc-utQCj4hh-HqkTaORjVua-udA980wN7mU4tX_3_6aPOGo2hhqk5-Qg-2mj29gwbR1bwer-A2OJhjG priority: 102 providerName: ProQuest |
Title | Mildly elevated serum bilirubin and its correlations with lipid levels among male patients undergoing health checkups |
URI | https://www.proquest.com/docview/2902132906 https://www.proquest.com/docview/2898313025 https://pubmed.ncbi.nlm.nih.gov/PMC10694953 https://doaj.org/article/ad8be12b66944fa4b57e5e38cdcb64d3 |
Volume | 22 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9NAEF_uA8QX0TvF6llWEH2QaHc32WweRHpyx1HoIWqhb8t-5Qy2aW0azv73zqRpMXqPviSQ3YXdnZnM_Hbng5BXoNWYdImNgokxJIfJyBofIgnQmTGbq0RhcPL4Wl5N4tE0mR6QXbmjdgOrO6Ed1pOarGbvfv3cfASB_9AIvJLvK9BZcRyB9gFgnKVZdHtIjkEzpVjRYBzvbxU4YHa5C5y5c1xHOTU5_P_9U__tPfmHOrp8SB60diQdbgn_iByE8oScDkvA0PMNfU0bz87myPyE3Bu3F-inpB4XMz_bUIwqByvTU-DAek7RQ3ZVA0impvS0WFfUYdWO1k-O4mEtnRXLwtMZOhlVtKlRROcwZ9pmZq0ohqOtbhagC-k2upICQ7gf9bJ6TCaXF98-XUVt5YXIxRlfR7kbyIwnOYCzgeGJCza3LjcgrHHGPHeCW2aV5Q4egK6ZSUSwjgkjfJDSePGEHJWLMjwlNGQDL7jyygkZWwNg3KVB8dwwn4s0SXrk7W7L9XKbYEM3wERJvSWQBgLphkD6tkfOkSr7npgcu_mwWN3oVta08coGxq2UMDo3sU3SkAShnHdWxl70yBukqUamAgo600YiwIQxGZYeYlbAFCxb6HnW6Qmi57rNO67QO87VPAOzSWAW_R55uW_GkejOVoZFDX1UpgReGcPyVYebOivrtpTF9yb9N8NY5SwRz_7HXjwn9zkKADroxGfkaL2qwwsws9a2Tw7Tadonx8Ph6OsI3ucX15-_9JtDi34jV78BPdsu7g |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGkIAXBBtohQFG4uMBRWvs2HEeECofU8fWPW3S3oy_MiratDSNqv5T_I3cpclGQOJtL32InTTO3fn8s-93R8gr8GqxdMJGwSRIyYllZI0PkQToHMc2V0IhOXl0KofnydcLcbFFfrVcGAyrbOfEeqL2M4d75AcsA2_EMTn5h_nPCKtG4elqW0JjoxbHYb0CyFa-P_oM8n3N2OGXs0_DqKkqELkkY8sod32ZMZED8OgbJlywuXW5AUVMstgzx5mNrbLMwQ8gx9gIHqyLueE-SGk8h-feIrdhWH0Ee-nFNcDrp1K2xBwlD0rwpUkSgVcEwJ6lWbTqOL-6RsC_nuDv6Mw_3N3hA3K_WafSwUaxHpKtUOyQ3UEBGH26pm9oHTlab8nvkDuj5oB-l1Sj8cRP1hRZ67CK9RQ0vJpSjMBdVADCqSk8HS9L6rAqSBOHR3EzmE7G87GnEwxiKmldA4lO4Z1pk_m1pEh3W1zOwNfSDXuTgsK5H9W8fETOb0QGj8l2MSvCHqEh63vOlFeOy8QaAPsuDYrlJvY5T4XokXftJ9fzTQIPXQMfJfVGQBoEpGsB6VWPfESpXPXE5Nv1hdniUje2rI1XNsTMSgl35yaxIg0icOW8szLxvEfeokw1ThEgQWcapgO8MCbb0gPMOpjCyhl67nd6gmm7bnOrFbqZWkp9bQg98vKqGe_EcLkizCroozLF8Ugahq862tQZWbelGH-v04vHyIXOBH_y_39_Qe4Oz0Yn-uTo9PgpucdQzTHMJ9kn28tFFZ7BYm1pn9cWQsm3mzbJ34fbVxk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mildly+elevated+serum+bilirubin+and+its+correlations+with+lipid+levels+among+male+patients+undergoing+health+checkups&rft.jtitle=Lipids+in+health+and+disease&rft.au=Xin+Bai&rft.au=Jing+Qiao&rft.au=Hong+Zhang&rft.date=2023-12-04&rft.pub=BMC&rft.eissn=1476-511X&rft.volume=22&rft.issue=1&rft.spage=1&rft.epage=8&rft_id=info:doi/10.1186%2Fs12944-023-01979-w&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_ad8be12b66944fa4b57e5e38cdcb64d3 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-511X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-511X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-511X&client=summon |